ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB)
CUSIP: 045396207
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per shares (the "Shares")
- Shares outstanding
- 15,738,333
- Total 13F shares
- 1,026,987
- Share change
- -148,144
- Total reported value
- $15,540,749
- Price per share
- $15.14
- Number of holders
- 30
- Value change
- -$2,242,995
- Number of buys
- 12
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 045396207?
CUSIP 045396207 identifies ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 045396207:
Top shareholders of ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3%
|
468,000
|
$6,420,960 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
200,458
|
$2,750,284 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.78%
|
123,458
|
$1,693,844 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
77,233
|
$1,059,636 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
54,911
|
$753,379 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
54,409
|
$746,652 | — | 30 Jun 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.32%
|
49,996
|
$685,945 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.16%
|
25,394
|
$348,406 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
17,400
|
$238,728 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
14,500
|
$198,940 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
13,558
|
$184,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
12,809
|
$175,739 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
12,746
|
$174,875 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.08%
|
12,220
|
$167,658 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
11,567
|
$158,699 | — | 30 Jun 2024 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.06%
|
9,016
|
$123,700 | — | 30 Jun 2024 | |
| Amundi |
13F
|
Individual |
0.05%
|
7,934
|
$96,398 | — | 30 Jun 2024 | |
| Michael P. Samar |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
77,228
|
$61,782 | — | 25 Jul 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
2,994
|
$41,078 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,949
|
$40,461 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
2,562
|
$35,151 | — | 30 Jun 2024 | |
| Luisa M. Stamm |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
152,815
mixed-class rows
|
$32,252 | — | 29 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
780
|
$10,702 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
190
|
$2,606 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
67
|
$919 | — | 30 Jun 2024 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
55
|
$803 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
46
|
$631 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$41 | — | 30 Jun 2024 | |
| Frazier Financial Advisors, LLC |
13F
|
Company |
0%
|
1
|
$14 | — | 30 Jun 2024 | |
| Richard D. DiMarchi |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 25 May 2022 | |
| Myron Z. Holubiak |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
— | — | 20 May 2021 |
Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB) as of Q3 2024
As of 30 Sep 2024,
ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,026,987 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, Acuitas Investments, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, FEDERATED HERMES, INC., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
27
Q3 2024 holders
30
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.